Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...
Amazon has started issuing payments to eligible Prime members as part of a $2.5 billion settlement over federal allegations that it misled customers. The online retailer agreed to the payouts in ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Prim is the newest venue from the creators of Ghost Baby. Several bottles are on display at the bar. Ross Van Pelt To continue reading this content, please enable ...
The Enquirer's new Going In series is a companion series to Going Up, giving you details and an inside look into the region's new construction projects. Submit suggestions to [email protected] or ...
Is 170,141,183,460,469,231,731,687,303,715,884,105,727 prime? Before you ask the Internet for an answer, can you consider how you might answer that question without a ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results